相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial
Paul M. Ridker et al.
LANCET (2017)
CD47 overexpression is associated with decreased neutrophil apoptosis/phagocytosis and poor prognosis in non-small-cell lung cancer patients
Lourdes Barrera et al.
BRITISH JOURNAL OF CANCER (2017)
The emerging role of myeloid-derived suppressor cells in lung diseases
Saeed Kolahian et al.
EUROPEAN RESPIRATORY JOURNAL (2016)
The Role of Tumor-Infiltrating Lymphocytes in Development, Progression, and Prognosis of Non-Small Cell Lung Cancer
Roy M. Bremnes et al.
JOURNAL OF THORACIC ONCOLOGY (2016)
Implications of MDSCs-targeting in lung cancer chemo-immunotherapeutics
Dickson Adah et al.
PHARMACOLOGICAL RESEARCH (2016)
Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards
Vincenzo Bronte et al.
NATURE COMMUNICATIONS (2016)
Clinical Implications of the Interleukin 27 Serum Level in Breast Cancer
Dapeng Lu et al.
JOURNAL OF INVESTIGATIVE MEDICINE (2016)
Neutrophils in cancer: neutral no more
Seth B. Coffelt et al.
NATURE REVIEWS CANCER (2016)
Regulation of Tumor Metastasis by Myeloid-Derived Suppressor Cells
Thomas Condamine et al.
ANNUAL REVIEW OF MEDICINE, VOL 66 (2015)
Myeloid-derived suppressor cells in the tumor microenvironment: expect the unexpected
Douglas Marvel et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Tumor-induced myeloid deviation: when myeloid-derived suppressor cells meet tumor-associated macrophages
Stefano Ugel et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Objective Measurement and Clinical Significance of TILs in Non-Small Cell Lung Cancer
Kurt A. Schalper et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Survival in Patients With Severe Lymphopenia Following Treatment With Radiation and Chemotherapy for Newly Diagnosed Solid Tumors
Stuart A. Grossman et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2015)
IL1B gene polymorphisms, age and the risk of non-small cell lung cancer in a Chinese population
Yanan Li et al.
LUNG CANCER (2015)
Objective Measurement and Clinical Significance of TILs in Non-Small Cell Lung Cancer
Kurt A. Schalper et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
A novel subset of B7-H3+CD14+HLA-DR-/low myeloid-derived suppressor cells are associated with progression of human NSCLC
Guangbo Zhang et al.
ONCOIMMUNOLOGY (2015)
Cytokine profile determined by data-mining analysis set into clusters of non-small-cell lung cancer patients according to prognosis
L. Barrera et al.
ANNALS OF ONCOLOGY (2015)
Immune cell promotion of metastasis
Takanori Kitamura et al.
NATURE REVIEWS IMMUNOLOGY (2015)
Myeloid-derived suppressor cell heterogeneity in human cancers
Samantha Solito et al.
YEAR IN IMMUNOLOGY: MYELOID CELLS AND INFLAMMATION (2014)
Cancer Statistics, 2014
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2014)
New insights into cancer immunoediting and its three component phases elimination, equilibrium and escape
Deepak Mittal et al.
CURRENT OPINION IN IMMUNOLOGY (2014)
Myeloid-Derived Suppressor Activity Is Mediated by Monocytic Lineages Maintained by Continuous Inhibition of Extrinsic and Intrinsic Death Pathways
Jessica M. Haverkamp et al.
IMMUNITY (2014)
The Role of Interleukin 17 in Tumour Proliferation, Angiogenesis, and Metastasis
Bob Yang et al.
MEDIATORS OF INFLAMMATION (2014)
A Circulating Subpopulation of Monocytic Myeloid-Derived Suppressor Cells as an Independent Prognostic/Predictive Factor in Untreated Non-Small Lung Cancer Patients
Eleni-Kyriaki Vetsika et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2014)
Increased CD14+HLA-DR-/low myeloid-derived suppressor cells correlate with extrathoracic metastasis and poor response to chemotherapy in non-small cell lung cancer patients
Ang Huang et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2013)
Treatment-related Lymphopenia in Patients With Stage III Non-Small-Cell Lung Cancer
Jian L. Campian et al.
CANCER INVESTIGATION (2013)
IL-27 inhibits epithelial-mesenchymal transition and angiogenic factor production in a STAT1-dominant pathway in human non-small cell lung cancer
Puja Kachroo et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2013)
Expression of IL-27 by Tumor Cells in InvasCutaneous and Metastatic Melanomas
Julie Gonin et al.
PLOS ONE (2013)
History of myeloid-derived suppressor cells
James E. Talmadge et al.
NATURE REVIEWS CANCER (2013)
CD14+S100A9+ Monocytic Myeloid-derived Suppressor Cells and Their Clinical Relevance in Non-Small Cell Lung Cancer
Po-Hao Feng et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2012)
Myeloid suppressor cells and immune modulation in lung cancer
Minu K. Srivastava et al.
IMMUNOTHERAPY (2012)
IRF-8 Controls Melanoma Progression by Regulating the Cross Talk between Cancer and Immune Cells within the Tumor Microenvironment
Fabrizio Mattei et al.
NEOPLASIA (2012)
IL-17A is a central regulator of lung tumor growth
Sarah Reppert et al.
ONCOIMMUNOLOGY (2012)
Coordinated regulation of myeloid cells by tumours
Dmitry I. Gabrilovich et al.
NATURE REVIEWS IMMUNOLOGY (2012)
The immune contexture in human tumours: impact on clinical outcome
Wolf Herman Fridman et al.
NATURE REVIEWS CANCER (2012)
Antitumor activity of type III interferon alone or in combination with type I interferon against human non-small cell lung cancer
Hitomi Fujie et al.
CANCER SCIENCE (2011)
Identification of Epstein-Barr Virus-Induced Gene 3 as a Novel Serum and Tissue Biomarker and a Therapeutic Target for Lung Cancer
Ryohei Nishino et al.
CLINICAL CANCER RESEARCH (2011)
Chemotherapy with or without low-dose interleukin-2 in advanced non-small cell lung cancer: results from a phase III randomized multicentric trial
Laura Ridolfi et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2011)
Myeloid-derived suppressor cells are implicated in regulating permissiveness for tumor metastasis during mouse gestation
Laetitia A. Mauti et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Microenvironment-Derived IL-1 and IL-17 Interact in the Control of Lung Metastasis
Yaron Carmi et al.
JOURNAL OF IMMUNOLOGY (2011)
Association of nutritional status and serum albumin levels with development of toxicity in patients with advanced non-small cell lung cancer treated with paclitaxel-cisplatin chemotherapy: a prospective study
Oscar Arrieta et al.
BMC CANCER (2010)
Role of interleukin-17 in lymphangiogenesis in non-small-cell lung cancer: Enhanced production of vascular endothelial growth factor C in non-small-cell lung carcinoma cells
Xi Chen et al.
CANCER SCIENCE (2010)
Population alterations of l-arginase- and inducible nitric oxide synthase-expressed CD11b(+)/CD14(-)/CD15(+)/CD33(+) myeloid-derived suppressor cells and CD8(+) T lymphocytes in patients with advanced-stage non-small cell lung cancer
Chien-Ying Liu et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2010)
IL1B rs1143634 Polymorphism, Cigarette Smoking, Alcohol Use, and Lung Cancer Risk in a Japanese Population
Chikako Kiyohara et al.
JOURNAL OF THORACIC ONCOLOGY (2010)
Increased IL-17-producing cells correlate with poor survival and lymphangiogenesis in NSCLC patients
Xi Chen et al.
LUNG CANCER (2010)
Caspase 1-Independent Activation of Interleukin-1β in Neutrophil-Predominant Inflammation
Monica Guma et al.
ARTHRITIS AND RHEUMATISM (2009)
Inflammatory Arthritis in Caspase 1 Gene-Deficient Mice Contribution of Proteinase 3 to Caspase 1-Independent Production of Bioactive Interleukin-1β
Leo A. B. Joosten et al.
ARTHRITIS AND RHEUMATISM (2009)
Second-line treatment of non-small cell lung cancer by biweekly gemcitabine and docetaxel plus /- granulocyte-macrophage colony stimulating factor and low dose aldesleukine
Pierpaolo Correale et al.
CANCER BIOLOGY & THERAPY (2009)
A specific interleukin-1B haplotype correlates with high levels of IL1B mRNA in the lung and increased risk of non-small cell lung cancer
Nina E. Landvik et al.
CARCINOGENESIS (2009)
Lung cancer patients' CD4+ T cells are activated in vitro by MHC II cell-based vaccines despite the presence of myeloid-derived suppressor cells
Minu K. Srivastava et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2008)
Arginine regulation by myeloid derived suppressor cells and tolerance in cancer: mechanisms and therapeutic perspectives
Paulo C. Rodriguez et al.
IMMUNOLOGICAL REVIEWS (2008)
Molecular origins of cancer: Lung cancer
Roy S. Herbst et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Reduced inflammation in the tumor microenvironment delays the accumulation of myeloid-derived suppressor cells and limits tumor progression
Stephanie K. Bunt et al.
CANCER RESEARCH (2007)
Immune surveillance of tumors
Jeremy B. Swann et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
All-trans-retinoic acid improves differentiation of myeloid cells and immune response in cancer patients
Noweeda Mirza et al.
CANCER RESEARCH (2006)
Effects of micro-environment- and malignant cell-derived interleukin-1 in carcinogenesis, tumour invasiveness and tumour-host interactions
RN Apte et al.
EUROPEAN JOURNAL OF CANCER (2006)
Myeloid suppressor cells in cancer: Recruitment, phenotype, properties, and mechanisms of immune suppression
P Serafini et al.
SEMINARS IN CANCER BIOLOGY (2006)
CD11b+/Gr-1+ immature myeloid cells mediate suppression of T cells in mice bearing tumors of IL-1β-secreting cells
XP Song et al.
JOURNAL OF IMMUNOLOGY (2005)
Arginase-producing myeloid suppressor cells in renal cell carcinoma patients: A mechanism of tumor evasion
AH Zea et al.
CANCER RESEARCH (2005)
Polymorphisms of the interleukin-1β gene are associated with increased risk of non-small cell lung cancer
S Zienolddiny et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Arginase I production in the tumor microenvironment by mature myeloid cells inhibits T-cell receptor expression and antigen-specific T-cell responses
PC Rodriguez et al.
CANCER RESEARCH (2004)
Increased production of immature myeloid cells in cancer patients: A mechanism of immunosuppression in cancer
B Almand et al.
JOURNAL OF IMMUNOLOGY (2001)
分享论文
